A Phase I Study of BMS 986301 Monotherapy and Combination Therapy with Nivolumab and Ipilimumab in Participants with Advanced Solid Cancers

At a Glance

IRB#IRB18-1829

Lead PhysicianJason Luke

Collaborator(s)N/A

EligibilityNot Recruiting